{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:45:12Z","timestamp":1788871512653,"version":"build-2803163510"},"reference-count":35,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,3]]},"DOI":"10.20945\/2359-3997000000497","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T13:39:29Z","timestamp":1654522769000},"source":"Crossref","is-referenced-by-count":12,"title":["Relationship of inflammatory and metabolic parameters in adolescents with PCOS: BMI matched case-control study"],"prefix":"10.20945","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7839-6963","authenticated-orcid":false,"given":"Aysun Tekeli","family":"Ta\u015fk\u00f6m\u00fcr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3178-8297","authenticated-orcid":false,"given":"\u00d6zlem","family":"Erten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"key":"key20220606093923_B1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jsbmb.2018.04.008","article-title":"Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy","volume":"182","author":"Patel","year":"2018","unstructured":"Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27-36.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"11","key":"key20220606093923_B2","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.4158\/EP15748.DSC","article-title":"American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and Pcos Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome \u2013 Part 1","volume":"21","author":"Goodman","year":"2015","unstructured":"Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and Pcos Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome \u2013 Part 1. Endocr Pract. 2015;21(11):1291-300.","journal-title":"Endocr Pract"},{"issue":"2","key":"key20220606093923_B3","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.fertnstert.2013.04.001","article-title":"Prevalence of polycystic ovary syndrome in adolescents","volume":"100","author":"Christensen","year":"2013","unstructured":"Christensen SB, Black MH, Smith N, Martinez MM, Jacobsen SJ, Porter AH, et al. Prevalence of polycystic ovary syndrome in adolescents. Fertil Steril. 2013;100(2):470-7.","journal-title":"Fertil Steril"},{"issue":"1","key":"key20220606093923_B4","doi-asserted-by":"crossref","first-page":"28.e25","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","unstructured":"Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97(1):28-38.e25.","journal-title":"Fertil Steril"},{"issue":"6","key":"key20220606093923_B5","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","unstructured":"Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89(6):2745-9.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"key20220606093923_B6","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1210\/jc.2008-1198","article-title":"Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome","volume":"93","author":"Rossi","year":"2008","unstructured":"Rossi B, Sukalich S, Droz J, Griffin A, Cook S, Blumkin A, et al. Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93(12):4780-6.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key20220606093923_B7","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/cen.13808","article-title":"Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS","volume":"89","author":"Shorakae","year":"2018","unstructured":"Shorakae S, Ranasinha S, Abell S, Lambert G, Lambert E, de Courten B, et al. Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS. Clin Endocrinol. 2018;89(5):628-33.","journal-title":"Clin Endocrinol"},{"issue":"6","key":"key20220606093923_B8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/09513590.2015.1130807","article-title":"Cystatin C, a novel cardiometabolic risk marker in women with polycystic ovary syndrome","volume":"32","author":"Yildirim","year":"2016","unstructured":"Yildirim A, Yildizhan B, Anik Ilhan G, Pekin T. Cystatin C, a novel cardiometabolic risk marker in women with polycystic ovary syndrome. Gynecol Endocrinol. 2016;32(6):457-9.","journal-title":"Gynecol Endocrinol"},{"key":"key20220606093923_B9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.lfs.2018.04.013","article-title":"On the role of cystatin C in cancer progression","volume":"202","author":"Leto","year":"2018","unstructured":"Leto G, Crescimanno M, Flandina C. On the role of cystatin C in cancer progression. Life Sci. 2018;202:152-60.","journal-title":"Life Sci"},{"issue":"4","key":"key20220606093923_B10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jpag.2015.12.005","article-title":"The Predictive Role of Serum Cystatin C Levels in Polycystic Ovary Syndrome in Adolescents","volume":"29","author":"\u00c7\u0131nar","year":"2016","unstructured":"\u00c7\u0131nar M, Aksoy RT, G\u00fczel A, Tokmak A, \u00c7andar T, Tas\u00c7\u00e7\u0131 Y. The Predictive Role of Serum Cystatin C Levels in Polycystic Ovary Syndrome in Adolescents. J Pediatr Adolesc Gynecol. 2016;29(4):353-6.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"5","key":"key20220606093923_B11","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/jcla.21920","article-title":"Association of Serum hs-CRP Levels With the Presence of Obesity, Diabetes Mellitus, and Other Cardiovascular Risk Factors","volume":"30","author":"Ebrahimi","year":"2016","unstructured":"Ebrahimi M, Heidari-Bakavoli AR, Shoeibi S, Mirhafez SR, Moohebati M, Esmaily H, et al. Association of Serum hs-CRP Levels With the Presence of Obesity, Diabetes Mellitus, and Other Cardiovascular Risk Factors. J Clin Lab Anal. 2016;30(5):672-6.","journal-title":"J Clin Lab Anal"},{"issue":"3","key":"key20220606093923_B12","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/14397595.2015.1091136","article-title":"Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients","volume":"26","author":"Qin","year":"2016","unstructured":"Qin B, Ma N, Tang Q, Wei T, Yang M, Fu H, et al. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol. 2016;26(3):372-6.","journal-title":"Mod Rheumatol"},{"key":"key20220606093923_B13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.intimp.2016.04.006","article-title":"Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus","volume":"36","author":"Wu","year":"2016","unstructured":"Wu Y, Chen Y, Yang X, Chen L, Yang Y. Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus. Int Immunopharmacol. 2016;36:94-9.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"key20220606093923_B14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40618-015-0335-2","article-title":"The mean platelet volume and neutrophil to lymphocyte ratio in obese and lean patients with polycystic ovary syndrome","volume":"39","author":"Yilmaz","year":"2016","unstructured":"Yilmaz MA, Duran C, Basaran M. The mean platelet volume and neutrophil to lymphocyte ratio in obese and lean patients with polycystic ovary syndrome. J Endocrinol Invest. 2016;39(1):45-53.","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"key20220606093923_B15","article-title":"Correlation of platelet to lymphocyte and neutrophil to lymphocyte ratio with hormonal and metabolic parameters in women with PCOS","volume":"34","author":"Pergialiotis","year":"2018","unstructured":"Pergialiotis V, Trakakis E, Parthenis C, Hatziagelaki E, Chrelias C, Thomakos N, et al. Correlation of platelet to lymphocyte and neutrophil to lymphocyte ratio with hormonal and metabolic parameters in women with PCOS. Horm Mol Biol Clin Investig. 2018;34(3).","journal-title":"Horm Mol Biol Clin Investig"},{"key":"key20220606093923_B16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1477-7819-12-58","article-title":"Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma","volume":"12","author":"Feng","year":"2014","unstructured":"Feng JF, Huang Y, Chen QX. Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma. World J Surg Oncol. 2014;12:58.","journal-title":"World J Surg Oncol"},{"key":"key20220606093923_B17","first-page":"577","article-title":"Age limits and adolescents","volume-title":"Paediatr Child Health","year":"2003","unstructured":"Age limits and adolescents. Paediatr Child Health. 2003;8(9):577-8."},{"key":"key20220606093923_B18","doi-asserted-by":"crossref","DOI":"10.1159\/000375530","article-title":"The Diagnosis of Polycystic Ovary Syndrome during Adolescence","author":"Witchel","year":"2015","unstructured":"Witchel SF, Oberfield S, Rosenfield RL, Codner E, Bonny A, Ib\u00e1\u00f1ez L, et al. The Diagnosis of Polycystic Ovary Syndrome during Adolescence. Horm Res Paediatr. 2015.","journal-title":"Horm Res Paediatr"},{"issue":"3","key":"key20220606093923_B19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/cen.13795","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"89","author":"Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2018;89(3):251-68.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"key20220606093923_B20","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602-18.","journal-title":"Hum Reprod"},{"issue":"3","key":"key20220606093923_B21","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/humupd\/dmt061","article-title":"Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"20","author":"Dewailly","year":"2014","unstructured":"Dewailly D, Lujan ME, Carmina E, Cedars MI, Laven J, Norman RJ, et al. Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update. 2014;20(3):334-52.","journal-title":"Hum Reprod Update"},{"issue":"2","key":"key20220606093923_B22","doi-asserted-by":"crossref","first-page":"702.e1-2","DOI":"10.1016\/j.fertnstert.2010.06.015","article-title":"Polycystic ovarian morphology in postmenarchal adolescents","volume":"95","author":"Codner","year":"2011","unstructured":"Codner E, Villarroel C, Eyzaguirre FC, L\u00f3pez P, Merino PM, P\u00e9rez-Bravo F, et al. Polycystic ovarian morphology in postmenarchal adolescents. Fertil Steril. 2011;95(2):702-6.e1-2.","journal-title":"Fertil Steril"},{"key":"key20220606093923_B23","year":"2000","unstructured":"Developed by the National Center for Health Statistics in collaboration with the National Center for Chronic Disease Prevention and Health Promotion. 2000. Available from: http:\/\/www.cdc.gov\/growthcharts","journal-title":"Developed by the National Center for Health Statistics in collaboration with the National Center for Chronic Disease Prevention and Health Promotion"},{"key":"key20220606093923_B24","volume-title":"WHO Child Growth Standards: length\/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development","author":"WHO Multicentre Growth Reference Study Group","year":"2006","unstructured":"WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards: length\/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. Geneva: WHO; 2006."},{"issue":"12","key":"key20220606093923_B25","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","unstructured":"Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352(12):1223-36.","journal-title":"N Engl J Med"},{"issue":"5","key":"key20220606093923_B26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1542\/pir.2014-0095","article-title":"Metabolic Syndrome in Children and Adolescents","volume":"37","author":"Wittcopp","year":"2016","unstructured":"Wittcopp C, Conroy R. Metabolic Syndrome in Children and Adolescents. Pediatr Rev. 2016;37(5):193-202.","journal-title":"Pediatr Rev"},{"issue":"Suppl 1","key":"key20220606093923_B27","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.fertnstert.2006.04.015","article-title":"Clinical expression of polycystic ovary syndrome in adolescent girls","volume":"86","author":"Sultan","year":"2006","unstructured":"Sultan C, Paris F. Clinical expression of polycystic ovary syndrome in adolescent girls. Fertil Steril. 2006;86 Suppl 1:S6.","journal-title":"Fertil Steril"},{"issue":"11","key":"key20220606093923_B28","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.numecd.2009.01.007","article-title":"Prominent role of low HDL-cholesterol in explaining the high prevalence of the metabolic syndrome in polycystic ovary syndrome","volume":"19","author":"Gambineri","year":"2009","unstructured":"Gambineri A, Repaci A, Patton L, Grassi I, Pocognoli P, Cognigni GE, et al. Prominent role of low HDL-cholesterol in explaining the high prevalence of the metabolic syndrome in polycystic ovary syndrome. Nutr Metab Cardiovasc Dis. 2009;19(11):797-804.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"key20220606093923_B29","first-page":"71","article-title":"Relationship between serum cystatin C and polycystic ovary syndrome","volume":"11","author":"Gozashti","year":"2013","unstructured":"Gozashti MH, Gholamhosseinian A, Musavi F, Mashrouteh M. Relationship between serum cystatin C and polycystic ovary syndrome. Iran J Reprod Med. 2013;11(1):71-6.","journal-title":"Iran J Reprod Med"},{"key":"key20220606093923_B30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.atherosclerosis.2017.02.003","article-title":"Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis","volume":"259","author":"Li","year":"2017","unstructured":"Li Y, Zhong X, Cheng G, Zhao C, Zhang L, Hong Y, et al. Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis. Atherosclerosis. 2017;259:75-82.","journal-title":"Atherosclerosis"},{"issue":"11","key":"key20220606093923_B31","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3109\/09513590.2014.924099","article-title":"High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS)","volume":"30","author":"Ganie","year":"2014","unstructured":"Ganie MA, Hassan S, Nisar S, Shamas N, Rashid A, Ahmed I, et al. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS). Gynecol Endocrinol. 2014;30(11):781-4.","journal-title":"Gynecol Endocrinol"},{"issue":"11","key":"key20220606093923_B32","first-page":"1213","article-title":"The association of hs-CRP and fibrinogen with anthropometric and lipid parameters in non-obese adolescent girls with polycystic ovary syndrome","volume":"31","author":"Mazibrada","year":"2018","unstructured":"Mazibrada I, Djuki\u00e7 T, Perovi\u00e7 S, Plje\u0161a-Ercegovac M, Plav\u0161i\u00e7 L, Bojanin D, et al. The association of hs-CRP and fibrinogen with anthropometric and lipid parameters in non-obese adolescent girls with polycystic ovary syndrome. J Pediatr Endocrinol Metab. 2018;31(11):1213-20.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"key20220606093923_B33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejogrb.2016.06.022","article-title":"Evaluation of hs-CRP and visseral adiposity index in patients with policystic ovary syndrome by clinical and laboratory findings","volume":"204","author":"\u00dcn","year":"2016","unstructured":"\u00dcn B, Dolap\u00e7\u0131o\u01e7lu KS, G\u00fcler Okyay A, S\u00c7ahin H, Beyaz\u0131t A. Evaluation of hs-CRP and visseral adiposity index in patients with policystic ovary syndrome by clinical and laboratory findings. Eur J Obstet Gynecol Reprod Biol. 2016;204:16-20.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"8","key":"key20220606093923_B34","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s40618-016-0446-4","article-title":"The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomes","volume":"39","author":"\u00c7ak\u0131ro\u01e7lu","year":"2016","unstructured":"\u00c7ak\u0131ro\u01e7lu Y, Vural F, Vural B. The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomes. J Endocr Investig. 2016;39(8):899-907.","journal-title":"J Endocr Investig"},{"issue":"2","key":"key20220606093923_B35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00404-014-3199-3","article-title":"The effect of obesity on inflammatory markers in patients with PCOS: a BMI-matched case-control study","volume":"290","author":"Keskin Kurt","year":"2014","unstructured":"Keskin Kurt R, Okyay AG, Hakverdi AU, Gungoren A, Dolapcioglu KS, Karateke A, et al. The effect of obesity on inflammatory markers in patients with PCOS: a BMI-matched case-control study. Arch Gynecol Obstet. 2014;290(2):315-9.","journal-title":"Arch Gynecol Obstet"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T13:39:53Z","timestamp":1654522793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/relationship-of-inflammatory-and-metabolic-parameters-in-adolescents-with-pcos-bmi-matched-case-control-study\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,3]]},"references-count":35,"alternative-id":["10.20945\/2359-3997000000497"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000497","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,3]]}}}